Effects of oral contraceptive, synthetic progestogen or natural estrogen pre-treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol

Human Reproduction

Volumn 22, Issue 1, 2007, Pages 109-116

  Cédrin Durnerin, Isabelle ^a   Bstandig B ^b   Parneix, I ^c   Bied Damon, V ^d   Avril, C ^e   Decanter, C ^f   Hugues, J N ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^c Clinique Jean Villar   (France)

^d Clinique de Monplaisir   (France)

^e Clinique Saint Antoine   (France)

^f LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

GnRH antagonist; Natural estrogen; Oral contraceptive pill; Pre treatment; Progestogen

Indexed keywords

CHORIONIC GONADOTROPIN; DESOGESTREL PLUS ETHINYLESTRADIOL; ESTRADIOL; ESTROGEN; FOLLITROPIN; GANIRELIX; GESTAGEN; GONADORELIN ANTAGONIST; GONADOTROPHINES CHORIONIQUES ENDO; GONADOTROPIN; LUTEINIZING HORMONE; NORETHISTERONE; NORETHISTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; PROVAMES; RECOMBINANT FOLLITROPIN; UTROGESTANB;

ADULT; ARTICLE; CELL SIZE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; INTRAUTERINE INSEMINATION; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOME ASSESSMENT; OVARY CYCLE; OVARY FOLLICLE CELL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

EID: 33845661575     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/del340     Document Type: Article

References (28)

1. Al-Inany H and Aboulghar M (2002) GnRH antagonist in assisted reproduction: A Cochrane review. Hum Reprod 17,874-885.
2. Anderson RE, Stein A, Paulson RJ, Stanczyk FZ, Vijod AG and Lobo RA (1990) Effects of norethindrone on gonadotropin and ovarian steroid secretion when used for cycle programming during in vitro fertilization. Fertil Steril 54,96-101.
3. Barmat LI, Chantilis SJ, Hurst BS and Dickey RP (2005) A randomised prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-antagonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization. Fertil Steril 83,321-330.
4. Biljan MM, Mahutte NG, Dean N, Hemmings R, Bissonnette F and Tan SL (1998) Effects of pre-treatment with oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates. Fertil Steril 70,1063-1069.
5. Cédrin-Durnerin I, Bulwa S, Hervé F, Martin-Pont B, Uzan M and Hugues JN (1996) The hormonal flare-up following GnRH agonist administration is influenced by a progestogen pretreatment. Hum Reprod 11,1859-1863.
6. Fanchin R, Cunha-Filho JS, Schonauer LM, Kadoch IJ, Cohen-Bacri P and Frydman R (2003a) Coordination of early antral follicles by luteal estradiol administration provides a basis for alternative controlled ovarian hyperstimulation regimens. Fertil Steril 79,316-321.
7. Fanchin R, Salomon L, Castelo-Branco A, Olivennes F, Frydman N and Frydman R (2003b) Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists. Hum Reprod 18,2698-2703.
8. Fauser BCJM and van Heusden AM (1997) Manipulation of human ovarian function: Physiological concepts and clinical consequences. Endocr Rev 18,71-106.
9. Frydman R, Forman R, Rainhorn JD, Belaisch-Allart J, Hazout A and Testart J (1986) A new approach to follicular stimulation for in vitro fertilization: Programmed oocyte retrieval. Fertil Steril 46,657-662.
10. Fukuda M, Fukuda K, Andersen CY and Byskov AG (2000) Does anovulation induced by oral contraceptives favor pregnancy during the following two menstrual cycles? Fertil Steril 73,742-747.
11. Gerli S, Remohi J, Partrizio P, Borrero C, Balmaceda JP, Silber SJ and Asch RH (1989) Programming of ovarian stimulation with norethindrone acetate in IVF/GIFT cycles. Hum Reprod 4,746-748.
12. van Heusden AM, Coelingh Bennink HJT and Fauser BCJM (2002) FSH and ovarian response: Spontaneous recovery of pituitary ovarian activity during the pill-free period vs. exogenous recombinant FSH during high-dose combined oral contraceptives. Clin Endocrinol 56,509-517.
13. Huirne JAF, van Loenen ACD, Schats R, McDonnell J, Hompes PGA, Schoemaker J, Homburg R and Lambalk CB (2005) Dose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF/ ICSI patients: Optimal changes in LH and progesterone for clinical pregnancy. Hum Reprod 20,359-367.
14. Huirne JA, Hugues JN, Pirard C, Fischl F, Sage JC, Pouly JL, Obruca A, Braat DM, van Loenen AC and Lambalk CB (2006) Cetrorelix in an oral contraceptive-pretreated stimulation cycle compared with buserelin in IVF/ICSI patients treated with r-hFSH: A randomized, multicentre, phase IIIb study. Hum Reprod 21,1408-1415.
15. Kolibianakis EM, Bourgain C, Albano C, Osmanagaoglu K, Smitz J, Van Steirteghem AC and Devroey P (2002) Effects of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up. Fertil Steril 78,1025-1029.
16. Kolibianakis EM, Albano C, Kahn J, Camus M, Tournaye H, Van Steirteghem AC and Devroey P (2003) Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy. Fertil Steril 79,873-880.
17. Kolibianakis EM, Zikopoulous K, Schiettecatte J, Smitz J, Tournaye H, Camus M, Van Steirteghem AC and Devroey P (2004) Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF. Hum Reprod 19,2490-2496.
18. Kolibianakis EM, Papanikolaou EG, Camus M, Tournaye H, Van Steirteghem AC and Devroey P (2006) Oral contraceptive pill pretreament on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial. Hum Reprod 21,352-357.
19. Lahlou N, Chabbert-Buffet N, Christin-Maitre S, Le Nestour E, Roger M and Bouchard P (1999) Main inhibitor of follicle stimulating hormone in the luteal-follicular transition: Inhibin A, oestradiol, or inhibin B? Hum Reprod 14,1190-1193.
20. le Nestour E, Marraoui J, Lahlou N, Roger M, de Ziegler D and Bouchard P (1993) Role of estradiol in the rise in follicle-stimulating hormone levels during the luteal-follicular transition. J Clin Endocrinol Metab 77,439-442.
21. Rombauts L, Healy D and Norman RJ. On behalf of the Orgalutran Scheduling Study Group. (2006) A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients. Hum Reprod 21,95-103.
22. Simon C, Oberyé J, Bellver J, Vidal C, Bosch E, Horcajadas JA, Murphy C, Adams S, Riesewijk A, Mannaerts B et al. (2005) Similar endometrial development in oocyte donors treated with either high-or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles. Hum Reprod 20,3318-3327.
23. Thatcher SS, Boyle HP, Glasier AF, Hillier SG and Baird DT (1988) A comparison of dosages of norethisterone for synchronisation of cycles in a fixed regimen of follicular augmentation and in vitro fertilization. Fertil Steril 49,848-853.
24. Tourgeman DE, Slater CC, Stanczyk FZ and Paulson RJ (2001) Endocrine and clinical effects of micronized estradiol administered vaginally or orally. Fertil Steril 75,200-202.
25. Tsai CC and Yen SCC (1971) The effect of ethinyl-estradiol administration during early follicular phase on the gonadotrophin levels and ovarian function. J Clin Endocrinol Metab 33,917-923.
26. Wardle PG, Foster PA, Michell JD, McLaughlin EA, Williams JAC, Corrigan E, Ray BD, McDermont AM and Hull MGR (1986) Norethisterone treatment to control timing of IVF cycle. Hum Reprod 1,455-457.
27. de Ziegler D, Jääskelaïnen AS, Brioschi PA, Fanchin R and Bulletti C (1998) Synchronisation of endogenous and exogenous FSH stimuli in controlled ovarian hyperstimulation (COH). Hum Reprod 13,561-564.
28. Zorn JR, Boyer P and Guichard A (1987) Never on a Sunday: Programming for IVF-ET and GIFT. Lancet 1(8529),385-386.